Diarrheal diseases caused by camplobacter species in humans pose a major threat to the health of the general public, to those in third world countries and of lower socioeconomic classes, and to U.S. military personnel deployed abroad. The elaborate laboratory diagnoses available at present are not well-suited for routine detection. A few recent studies have developed diagnostic tools using the flagellin gene for specific detection of bacteria from stool and water samples by PCR. The current proposal uses antiflagellar antibody coated magnetic beads to capture the bacteria from stool samples. The DNA from these captured bacteria will be used as a template for PCR amplification of the flagellar gene. A detection system using a simple ELISA assay will enable a high- throughput screening. After standardization, the entire procedure should be completed in less than 10 hours. The tremendous potential for such a kit is evident in its use for the diagnosis of campylobacter and could replace the currently used diagnostic tools.

Proposed Commercial Applications

This project aids in the easy, rapid and specific diagnosis of campylobacter in stool samples from patients suffering from enteritis and thus has exceptional application. It offers a tremendous commercial application as a diagnostic kit for campylobacter enteritis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43AI040757-01
Application #
2005313
Study Section
Special Emphasis Panel (ZRG5-MBC-1 (02))
Project Start
1997-09-01
Project End
1998-08-31
Budget Start
1997-09-01
Budget End
1998-08-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Bioserve Biotechnologies, Ltd
Department
Type
DUNS #
City
Laurel
State
MD
Country
United States
Zip Code
20707